Nestlé Holdings successfully completed its issuance of USD 1.5 bn 0.606% Notes due 2024, USD 500 m 1.150% Notes due 2027, USD 1 bn 1.500% Notes due 2028, USD 1 bn 1.875% Notes due 2031, USD 500 m 2.500% Notes due 2041 and USD 500 m 2.625% Notes due 2051. The Notes are
Tags :Homburger
Adecco Group has successfully priced its EUR 500 million Subordinated Fixed-to-Reset Rate Securities due 2082. Settlement will take place on September 21, 2021. The hybrid bonds were issued by Adecco International Financial Services B.V. and guaranteed, on a
Unigestion, an independent, specialist asset management company providing tailored solutions for investors worldwide, has invested in Home Instead, a provider of home care services, predominantly for the elderly.Home Instead is the exclusive franchisee of
On September 7, 2021, Adecco Group successfully raised approximately EUR 232.29 m (CHF 252.96 m) through the placement of 5.1 m new shares by way of an accelerated bookbuild offering. The offering was done by way of a private
Oviva, the digital health scaleup provider of diet and lifestyle coaching to people who deal with diet-related health challenges, has raised $80 million in Series C funding to reach millions of people across Europe. The round
Crown Holdings, the company specializing in the designing, manufacturing, and sale of packaging products and equipment for consumer and industrial products, has completed the previously announced sale of its European Tinplate business to KPS Capital
Holcim Finance (Luxembourg) completed its issuance of EUR 1 billion in aggregate principal amount of 0.500 per cent. Guaranteed Notes due 2030 under its Euro Medium Term Note Programme. The notes are guaranteed by Holcim, the holding company
Allgemeine Baugenossenschaft Zürich (ABZ), a non-profit housing cooperative, launched and priced its issuance of CHF 120 million total nominal amount of 0.25% Sustainability Bonds 2021-2031. The bonds have been offered in full compliance with the Financial
VectivBio Holding, clinical-stage biopharmaceutical company specialising in novel transformational treatments for severe rare conditions announced the acquisition of Comet Therapeutics, a biotechnology company that has been developing drugs to address previously untreatable inherited metabolic diseases.
HBM Healthcare Investments successfully issued CHF 100 million 1.125 per cent Bonds due 2027. The bonds will be admitted for trading and listing on the SIX Swiss Exchange. The advisors Homburger acted as counsel to HBM Healthcare
